Leading COVID-19 test method India 2020

Published by A. Minhas, Jul 12, 2023
As per the results of a large scale survey conducted across India in 2020, majority of the people of 57 percent had not taken any type of COVID-19 tests. However, 18 percent of the respondents took the molecular (reverse transcription polymerase chain reaction) test to test for COVID-19 virus.

Leading COVID-19 test method across India in 2020

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2021

Region

India

Survey time period

2020

Number of respondents

11,000 respondents

Special properties

among GOQii app users

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19) - economic impact in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19) - economic impact in India

Key indicators

7

Employment

6

Businesses

7

Retail and consumption

6

Relief and financial aid

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Chinese COVID-19 vaccinesCoronavirus COVID-19 in ChinaPharmaceutical industry in ChinaVaccine industry in ChinaCoronavirus disease (COVID-19) pandemic
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.